Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gamma-aminobutyric acid type A (GABA_A) receptor is a ligand-gated ion channel and the principal mediator of fast inhibitory neurotransmission in the central nervous system (CNS). The specific target described—alpha4-beta3-gamma subunit—refers to a pentameric assembly typically composed of two α4, two β3, and one γ (usually γ2) subunits. This combination determines the receptor’s localization, pharmacology, and physiological function. When activated by GABA binding, these receptors open their intrinsic chloride ion channel. Chloride influx hyperpolarizes neurons, inhibiting action potential firing. Alterations in expression or function of specific GABA_A receptor assemblies have been implicated in epilepsy, anxiety disorders, sleep disturbances, autism spectrum disorders, among others.
Ligand-gated chloride channel activity; Chloride influx hyperpolarizes neurons, inhibiting action potential firing.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-Aminobutyric Acid Type A Receptor Alpha4-Beta3-Gamma Subunit.